Rocakinogene sifuplasmid
Rocakinogene sifuplasmid Uses, Dosage, Side Effects, Food Interaction and all others data.
Rocakinogene sifuplasmid is under investigation in clinical trial NCT03491683 (INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-diagnosed Glioblastoma (GBM)).
| Trade Name | Rocakinogene sifuplasmid |
| Generic | Rocakinogene sifuplasmid |
| Rocakinogene sifuplasmid Other Names | Rocakinogene sifuplasmid |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Rocakinogene sifuplasmid
